Pasar al contenido principal

NUEVOS ANTIVIRALES MEDIANTE DISEÑO BASADO EN LA ESTRUCTURA DE PROTEINAS CLAVE EN LA INFECCION POR EL VIRUS DEL NILO OCCIDENTAL Y OTROS FLAVIVIRUS RELACIONADOS

PID2019-105117RR-C22

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Antivirals against (Re)emerging Flaviviruses: Should We Target the Virus or the Host?

  • Peréz-Pérez, María-Jesús
  • Saiz Calahorra, Juan Carlos
  • Priego, Eva María
  • Martín-Acebes, M. A.
The COVID pandemic has evidenced how vulnerable we are to emerging infectious diseases and how short our current armamentarium is. Flavivirus, single stranded RNA viruses transmitted by arthropods, are considered a global health challenge. No drugs to treat these infections have been approved. In this Viewpoint, we analyze the advantages and disadvantages of two different, but probably also complementary, therapeutic approaches: virus-targeting antivirals and host-targeting drugs, Our own research in the search of antivirals against West Nile virus and other flaviviruses is financed by grants PID2019- 105117RR-C22 and PID2019-105117RR-C21 funded by Ministerio de Ciencia e Innovación, Agencia Estatal de Investigación MCIN/AEI/10.13039/501100011033, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Hybridization Approach to Identify Salicylanilides as Inhibitors of Tubulin Polymerization and Signal Transducers and Activators of Transcription 3 (STAT3)

  • Gargantilla, Marta
  • Persoons, Leentje
  • Kauerová, Tereza
  • Río, Natalia del
  • Daelemans, Dirk
  • Priego, Eva María
  • Kollar, Peter
  • Peréz-Pérez, María-Jesús
The superimposition of the X-ray complexes of cyclohexanediones (i.e., TUB015), described by our research group, and nocodazole, within the colchicine binding site of tubulin provided an almost perfect overlap of both ligands. This structural information led us to propose hybrids of TUB015 and nocodazole using a salicylanilide core structure. Interestingly, salicylanilides, such as niclosamide, are well-established signal transducers and activators of transcription (STAT3) inhibitors with anticancer properties. Thus, different compounds with this new scaffold have been synthesized with the aim to identify compounds inhibiting tubulin polymerization and/or STAT3 signaling. As a result, we have identified new salicylanilides (6 and 16) that showed significant antiproliferative ac- tivity against a panel of cancer cells. Both compounds were able to reduce the levels of p-STAT3Tyr705 without affecting the total expression of STAT3. While compound 6 inhibited tubulin polymerization and arrested the cell cycle of DU145 cells at G2/M, similar to TUB015, compound 16 showed a more potent effect on inhibiting STAT3 phosphorylation and arrested the cell cycle at G1/G0, similar to niclosamide. In both cases, no toxicity towards PBMC cells was detected. Thus, the salicylanilides described here represent a new class of antiproliferative agents affecting tubulin polymerization and/or STAT3 phosphorylation., This research was funded by AECSIC, grant number PIE-201980E100 and by Agencia Estatal de Investigación (PID2019-105117RR-C22/AEI/10.13039/501100011033)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Allosteric Inhibition of Neutral Sphingomyelinase 2 (nSMase2) by DPTIP: From Antiflaviviral Activity to Deciphering Its Binding Site through In Silico Studies and Experimental Validation

  • Álvarez-Fernández, Hadrián
  • Mingo-Casas, Patricia
  • Blázquez, Ana B.
  • Caridi, Flavia
  • Saiz Calahorra, Juan Carlos
  • Peréz-Pérez, María-Jesús
  • Martín-Acebes, M. A.
  • Priego, Eva María
Flavivirus comprises globally emerging and re-emerging pathogens such as Zika virus (ZIKV), Dengue virus (DENV), and West Nile virus (WNV), among others. Although some vaccines are available, there is an unmet medical need as no effective antiviral treatment has been approved for flaviviral infections. The development of host-directed antivirals (HDAs) targeting host factors that are essential for viral replication cycle offers the opportunity for the development of broad-spectrum antivirals. In the case of flaviviruses, recent studies have revealed that neutral sphingomyelinase 2, (nSMase2), involved in lipid metabolism, plays a key role in WNV and ZIKV infection. As a proof of concept, we have determined the antiviral activity of the non-competitive nSMase2 inhibitor DPTIP against WNV and ZIKV virus. DPTIP showed potent antiviral activity with EC50 values of 0.26 μM and 1.56 μM for WNV and ZIKV, respectively. In order to unravel the allosteric binding site of DPTIP in nSMase2 and the details of the interaction, computational studies have been carried out. These studies have revealed that DPTIP could block the DK switch in nSMase2. Moreover, the analysis of the residues contributing to the binding identified His463 as a crucial residue. Interestingly, the inhibitory activity of DPTIP on the H463A mutant protein supported our hypothesis. Thus, an allosteric cavity in nSMase2 has been identified that can be exploited for the development of new inhibitors with anti-flaviviral activity., This work was supported by AECSIC, grant number PIE-201980E100 (to M.-J.P.-P.), by the Spanish Ministry of Science and Innovation AEI/10.13039/501100011033 grants PID2019-105117RR- C21 (to M.A.M-A) and PID2019-105117RR-C22 (to M.-J.P.-P) and by the European Commission—NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Plat- form, PTI+ Salud Global, grants SGL2103053 (to M.A.M.-A.) and SGL2103051 to (M.-J.P.-P.). P.M.-C. was supported by an FPI fellowship (PRE2020-093374) from AEI/10.13039/501100011033. H.Á.-F. was supported by an AEI contract (PEJ2018-002006-A)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Editorial: Lipids in host microbe interaction

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pharmacological Elevation of Cellular Dihydrosphingomyelin Provides a Novel Antiviral Strategy against West Nile Virus Infection

  • Jiménez de Oya, Nereida
  • San-Félix, Ana
  • Casasampere, Mireia
  • Blázquez, Ana B.
  • Mingo-Casas, Patricia
  • Escribano-Romero, Estela
  • Calvo Pinilla, Eva María
  • Poderoso, Teresa
  • Casas, Josefina
  • Saiz Calahorra, Juan Carlos
  • Peréz-Pérez, María-Jesús
  • Martín-Acebes, M. A.
The flavivirus life cycle is strictly dependent on cellular lipid metabolism. Polyphenols like gallic acid and its derivatives are promising lead compounds for new therapeutic agents as they can exert multiple pharmacological activities, including the alteration of lipid metabolism. The evaluation of our collection of polyphenols against West Nile virus (WNV), a representative medically relevant flavivirus, led to the identification of N,N'-(dodecane-1,12-diyl)bis(3,4,5-trihydroxybenzamide) and its 2,3,4-trihydroxybenzamide regioisomer as selective antivirals with low cytotoxicity and high antiviral activity (half-maximal effective concentrations [EC50s] of 2.2 and 0.24 μM, respectively, in Vero cells; EC50s of 2.2 and 1.9 μM, respectively, in SH-SY5Y cells). These polyphenols also inhibited the multiplication of other flaviviruses, namely, Usutu, dengue, and Zika viruses, exhibiting lower antiviral or negligible antiviral activity against other RNA viruses. The mechanism underlying their antiviral activity against WNV involved the alteration of sphingolipid metabolism. These compounds inhibited ceramide desaturase (Des1), promoting the accumulation of dihydrosphingomyelin (dhSM), a minor component of cellular sphingolipids with important roles in membrane properties. The addition of exogenous dhSM or Des1 blockage by using the reference inhibitor GT-11 {N-[(1R,2S)-2-hydroxy-1-hydroxymethyl-2-(2-tridecyl-1-cyclopropenyl)ethyl]octanamide} confirmed the involvement of this pathway in WNV infection. These results unveil the potential of novel antiviral strategies based on the modulation of the cellular levels of dhSM and Des1 activity for the control of flavivirus infection., We thank Theodore C. Pierson (National Institutes of Health, USA) for the subgenomic replicon of WNV. This work was supported by the Spanish Ministry of Science and Innovation AEI/10.13039/501100011033 under grants PID2019-105117RR-C21 (to M.A.M.-A.), PID2019-105117RR-C22 (to M.-J.P.-P.), and PID2020-119195RJ-I00 (to N.J.d.O.) and by the AECSIC under grant PIE-201980E100 (to M.-J.P.-P. and A.S.-F.). This research work was also funded by the European Commission-NextGenerationEU (regulation EU 2020/2094) through CSIC’s Global Health Platform (PTI Salud Global). P.M.-C. was supported by an FPI fellowship (PRE2020-093374) from AEI/10.13039/501100011033. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Identification of West Nile virus RNA-dependent RNA polymerase non-nucleoside inhibitors by real-time high throughput fluorescence screening

  • García-Zarandieta, Marta
  • Quesada, Ernesto
  • Martínez-Jiménez, María I.
  • Newnes, Cristina V
  • Fernández-Cabello, Víctor
  • Saez-Alvarez, Yanira
  • Blázquez, Ana B.
  • Escribano-Romero, Estela
  • Saiz Calahorra, Juan Carlos
  • Del Aguila, Carmen
  • Martín-Acebes, M. A.
  • Peréz-Pérez, María-Jesús
  • Agudo, Ruben
8 pág., West Nile virus (WNV) is a re-emergent mosquito-borne RNA virus that causes major outbreaks of encephalitis around the world. However, there is no therapeutic treatment to struggle against WNV, and the current treatment relies on alleviating symptoms. Therefore, due to the threat virus poses to animal and human health, there is an urgent need to come up with fast strategies to identify and assess effective antiviral compounds. A relevant target when developing drugs against RNA viruses is the viral RNA-dependent RNA polymerase (RdRp), responsible for the replication of the viral genome within a host cell. RdRps are key therapeutic targets based on their specificity for RNA and their essential role in the propagation of the infection. We have developed a fluorescence-based method to measure WNV RdRp activity in a fast and reliable real-time way. Interestingly, rilpivirine has shown in our assay inhibition of the WNV RdRp activity with an IC50 value of 3.3 μM and its antiviral activity was confirmed in cell cultures. Furthermore, this method has been extended to build up a high-throughput screening platform to identify WNV polymerase inhibitors. By screening a small chemical library, novel RdRp inhibitors 1-4 have been identified. When their antiviral activity was tested against WNV in cell culture, 4 exhibited an EC50 value of 2.5 μM and a selective index of 12.3. Thus, rilpivirine shows up as an interesting candidate for repurposing against flavivirus. Moreover, the here reported method allows the rapid identification of new WNV RdRp inhibitors., This work was supported by Spanish Ministry of Science and Innovation AEI/10.13039/501100011033 under grant PID2020-115432RB-I00 (to R.A) grant PID2019-105117RR-C21 (to MAM-A); PID2019-105117RR-C22 (to M-JP-P); and from AECSIC under grant PIE-201980E100 (to M-JP-P). This research work was also funded by the European Commission-NextGeneration EU (Regulation EU 2020/2094), through CSIC's Global Health Platform (PTI Salud Global)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Direct reductive amination of functionalized aldehydes with aniline derivatives of purines and 7-deazapurines

  • Orduña, José-María
  • Río, Natalia del
  • Peréz-Pérez, María-Jesús
Reductive amination plays a key role in the medicinal chemistry toolbox since it allows the mono alkylation of an amine or aniline. In this work, reductive amination of functionalized aldehydes with aniline derivatives of adenine and closely related 7-deazapurines has been successfully performed using H-cube technology so that imine formation and its reduction are performed “in situ”. The set-up procedure surmounts some of the drawbacks of “in batch” protocols by avoiding the handling of reductant reagents, long reaction times and tedious work-ups. The here described procedure allows a high conversion into the reductive amination products together with an easy work-up by just evaporation. More interestingly, this set-up does not require the presence of acids so that acid-sensitive protecting groups can be present both at the aldehyde and at the heterocycle., This work was supported by the Spanish Ministry of Science and Innovation AEI/10.13039/501100011033 grant PID2019- 105117RR-C22 (to M.-J. P.-P.), by AECSIC, grant number PIE-202380E090 (to M.-J. P.-P.) and by the European Commission – NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global). NdR thanks Fondo Social Europeo (Programa Operativo de Empleo Juvenil 2014–2020) and YEI (Comunidad de Madrid)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Development of a luminescence-based method for measuring West Nile Virus MTase activity and its application to screen for antivirals

  • Álvarez-Mínguez, Alejandra
  • Río, Natalia del
  • Blázquez, Ana-Belén
  • Casanova, Elena
  • Orduña, José-María
  • Camarero, Patricia
  • Hurtado-Marcos, Carolina
  • Águila, Carmen del
  • Peréz-Pérez, María-Jesús
  • Martín-Acebes, M. A.
  • Agudo, Rubén
West Nile virus (WNV) is a flavivirus responsible for causing febrile illness and severe neurological diseases, with an increasing impact on human health around the world. However, there is still no adequate therapeutic treatment available to struggle WNV infections. Therefore, there is an urgent need to develop new techniques to accelerate the discovery of drugs against this pathogen. The main protein implicated in the replication of WNV is the non-structural protein 5 (NS5). This multifunctional protein contains methyltransferase (MTase) activity involved in the capping formation at the 5′-end of RNA and the methylation of internal viral RNA residues, both functions being essential for viral processes, such as RNA translation and escape from the innate immune response. We have developed a straightforward luminescence-based assay to monitor the MTase activity of the WNV NS5 protein with potential for high-throughput screening. We have validated this method as a sensitive and suitable assay for the identification of WNV MTase inhibitors assessing the inhibitory effect of the broad MTase inhibitor sinefungin, a natural nucleoside analog of the universal methyl donor S-adenosyl methionine (SAM). The screening of a small series of purine derivatives identified an adenosine derivative as a dose-dependent inhibitor of the MTase activity. The antiviral efficacy of this compound was further confirmed in WNV infections, displaying a measurable antiviral effect. This result supports the utility of this novel method for the screening of inhibitors against WNV MTase activity, which can be of special relevance to the discovery and development of therapeutics against WNV., This work was supported by Ministerio de Ciencia e Innovación y Universidades, Agencia Estatal de Investigación MICIU/AEI/10.13039/ 501,100,011,033 under grants PID2020–115432RB-I00 (to RA), PID2019–105117RR-C21 (to MAM-A), PID2019–105117RR-C22 (to MJP-P), PID2022–137372OR-C21 (to MAM-A) and PID2022–137372ORC21 (to M-JP-P), by the European Commission—Next Generation EU through CSIC’s Global Health Platform (PTI Salud Global) (to M-JP-P and MAM-A) and by CSIC-PIE202380E090 (to M-JP-P). AA-M. is the recipient of an FPU-predoctoral fellowship FPU22/03025 granted by MICIU/AEI/10.13039/501,100,011,033 and the FSE+. The funders did not participate in the study design, data collection and interpretation, or the decision to submit the work for publication., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Neutral sphingomyelinase 2 inhibition alters inflammatory gene expression signatures in the brain of mice infected with West Nile virus

  • Mingo-Casas, Patricia
  • Álvarez-Fernández, Hadrián
  • Blázquez, Ana-Belén
  • Esteban, Ana
  • Escribano-Romero, Estela
  • Jiménez de Oya, Nereida
  • Calvo-Pinilla, Eva
  • Peréz-Pérez, María-Jesús
  • Priego, Eva María
  • Martín-Acebes, Miguel A
West Nile virus (WNV) is a neurotropic flavivirus transmitted by the bites of infected mosquitoes. Severe forms of the disease include meningitis, encephalitis, acute flaccid paralysis, or even death, and survivors develop long-lasting sequelae. The damage induced by WNV does not only stem from viral multiplication but also arises from immune-related pathology linked to neuroinflammation. Certain sphingolipids are key players in WNV infection, neurodegenerative diseases and inflammatory disorders. Neutral sphingomyelinase 2 (nSMase2), catalyzes the conversion of sphingomyelin into ceramide and is essential for flavivirus multiplication. Thus, nSMase2 constitutes a promising therapeutic target for the development of dual-acting antiviral and anti-inflammatory therapies against WNV. The effect of an orally bioavailable and brain-penetrating prodrug of the potent nSMase2 inhibitor DPTIP (DPTIP-P1) was studied in WNV-infected mice. While no reduction in the viral load in the brain of infected animals was observed, WNV-induced expression of inflammatory markers was modulated, resulting in a reduced IL-1β expression in brain. Transcriptomic analyses revealed that treatment with the DPTIP prodrug also modulated the expression of various genes related to immune cell function without altering antiviral innate response. Among others, DPTIP-P1 reduced the expression of Lyz2, an inducible genetic marker associated with macrophage infiltration, and modified the expression of genes related to T cell activation such as Trbc1 and Ptnp22. These results identify nSMase2 inhibitors as a new type of immune modulators of WNV infection. The neuroprotective effects exerted by DPTIP-P1 could contribute to mitigate WNV-induced neuroinflammation and sequelae., This work was supported by the Spanish Ministry of Science and Innovation AEI/10.13039/501100011033 under Grants PID2019- 105117RR-C21 (to MAMA), PID2019-105117RR-C22 (to MJPP) and PID2020-119195RJ-I00 (to NJO); Spanish Ministry of Science and Innovation AEI/10.13039/501100011033 and FEDER, EU under grants PID2022-137372OR-C21 (to MAMA), PID2022-137372OR-C22 (MJPP and EMP), by Comunidad de Madrid under grant TEC-2024/BIO-66/ SALAINDEC-CM (to MAMA) and by the European Commission—NextGenerationEU through CSIC’s Global Health Platform (PTI Salud Global). PMC was supported by an FPI fellowship from AEI/ 10.13039/501100011033 under Grant PRE2020-093374. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Design, synthesis and evaluation of arylpurine-based sinefungin mimetics as zika virus methyltransferase inhibitors

  • Río, Natalia del
  • Arribas-Álvarez, Iván
  • Orduña, José-María
  • Sutto-Ortiz, Priscila
  • Neyts, Johan
  • Kaptein, Suzanne
  • Decroly, Etienne
  • Priego, Eva María
  • Peréz-Pérez, María-Jesús
Arylpurine derivatives were designed and synthesized to mimic sinefungin by targeting the SAM/SAH binding site of zika virus (ZIKV) methyltransferase (MTase). These compounds incorporate adenine or 6-methyl-7-deazapurine bases, while the ribose of sinefungin has been replaced by an aniline, linked to its amino acid chain via a CO or a CH2 unit. Compounds 18, 29 and 31 inhibited ZIKV 2'-O-MTase activity. Docking studies showed that compounds 18 and 29 interact with both the purine and amino acid binding sites, effectively mimicking sinefungin. In contrast, compound 31 has its amino acid chain positioned above the ribose binding site. Notably, compound 18 exhibited modest antiviral activity against ZIKV., This work was supported by grant PID2019-105117RR-C22 (to MJPP) funded by the Spanish Ministry of Science and Innovation AEI/10.13039/501100011033; grant PID2022-137372OR-C22 (to MJPP and EMP), funded by MCIN/AEI/10.13039/ 501100011033 and by “ERDF A way of making Europe”; grant numberPIE-202380E090(toMJPP)funded by AE CSIC and Grant Agreement No. 101137229 (to MJPP, ED and JN) funded by European Union's Horizon Europe research and innovation programme. We thank Lieve Naesens for kindly providing the SH-SY5Y cells. We thank Caroline Collard and Elke Maas for excellent technical assistance., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Efficient blocking of Sars-CoV-2 entry through tryptophan derivatives interfering with the interaction of Ace2 with the viral spike

  • Gargantilla, Marta
  • Francés-Gómez, Clara
  • Adhav, Anmol
  • Martínez-Gualda, Belén
  • Marina, Alberto
  • Rubio, Vicente
  • San-Félix, Ana
  • Peréz-Pérez, María-Jesús
  • Geller, Ron
Resumen del póster presentado al International Symposium on Medicinal Chemistry, celebrado en Niza (Francia) del 4 al 8 de septiembre de 2022., The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the largest pandemic the world has suffered in recent years, COVID-19.1 Coronaviruses are characterized by spike proteins that are crucial for the entry process into the host cells. Particularly, the spike protein of SARS-CoV-2 binds to the human angiotensin converting enzyme 2 (ACE2) through its receptor binding domain (RBD) (Figure 1), leading to viral entry and subsequent infection of the host cell.1,2 Thus, inhibition of SARS-CoV-2 by blocking the interaction of the spike protein with ACE2 represents an appealing antiviral strategy that can be combined with the treatments already approved. Our research group has been extensively involved in the search for entry inhibitors of different virus, as recently reported for potent HIV and EV-A71 antivirals.3 In the current project, 200 compounds were evaluated as entry inhibitors in a HTS assay using VSV pseudoparticles expressing the SARS-CoV-2 spike protein in Vero cells. The identified hits, with a tryptophan scaffold, have been further explored through the synthesis of structural analogues. As a result, we have identified compounds able to block viral entry in the pseudoparticles assay with IC50 values in the low micromolar or submicromolar range and in the absence of toxicity to host cells (CC50>100 µM). Moreover, their antiviral activity has been confirmed against SARS-CoV-2 in Vero E6 and A549-ACE2 cells. Additionally, biophysical studies using microscale thermophoresis have evidenced that these compounds are able to interact with the RBD and spike of SARS-CoV-2 and significantly affect the KD of the interaction of the RBD with ACE2. Thus, these compounds represent an interesting alternative for the development of SARS-CoV-2 therapies and/or prevention., This research has been funded by Fondo Supera COVID-19 (Crue-CSIC-Santander), by the European Commission – NextGenerationEU (Regulation EU 2020/2094), through CSIC's Global Health Platform (PTI Salud Global) and by PID2019-105117RR-C22/ AEI / 10.13039/501100011033., No